Aussie Federal Court Overturns Ruling Against Merck In Vioxx Case
This article was originally published in PharmAsia News
Executive Summary
Merck Australia won a federal court decision overturning a lower-court ruling in a case involving the now-banned painkiller Vioxx (rofecoxib)